Sleep apnea in peritoneal dialysis: nocturnal versus continuous ambulatory treatment
Jeffrey Perl and Christopher T Chan*
Correspondence *Toronto General Hospital, 200 Elizabeth Street, 8N—Room 842, Toronto, ON M5G 2C4, Canada
Email christopher.chan@uhn.on.ca
This article has no abstract so we have provided the first paragraph of the full text.
Tang et al. demonstrated that NPD offers a therapeutic benefit over CAPD in its capacity to improve uremia-associated sleep apnea. The proposed mechanism is via superior time-averaged volume control during sleep and improved upper airway patency. This study makes an important contribution to the growing body of literature indicating that optimal control of uremia and volume in dialysis patients could serve as a treatment for concomitant sleep apnea.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Assessment of sleepiness in clinical practiceNature Medicine News and Views (01 Dec 1995)
